USA Life Sciences Database

Biotechgate

Biotechgate Global Database › Global Trial › Global Log-in ›

Database Life Science Map Statistics News & Events About us

News in the Life Sciences Industry
Results 1 - 20 out of 500 displayed.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 »

Roswell Park Study May Provide Clues to Treating Colorectal Cancer More Effectively in Younger Patients

A novel study led by medical oncologists Deepak Vadehra, DO, and Sarbajit Mukherjee, MD, MS, of Roswell Park Comprehensive Cancer Center is shedding light on factors that may affect treatment response in younger people with colorectal cancer. That information could guide the development of new treatments... Read more ››

By: PR Newswire Association LLC. - 04 Jun 2023

Related companies: Roswell Park Comprehensive Cancer Center

Innovent Updates Phase 1b Data of IBI939 (Anti-TIGIT Monoclonal Antibody) Combined with Sintilimab in Previously Untreated PD-L1-selected NSCLC at the 2023 ASCO Annual Meeting

Read more ››

By: PR Newswire Association LLC. - 04 Jun 2023

Related companies: Innovent Biologics (USA), Inc.

Replimune Presents RP1 Data from the IGNYTE anti-PD1 Failed Melanoma Cohort and RP2 Data in Uveal Melanoma at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

Read more ››

By: GlobeNewswire - 03 Jun 2023

Related companies: Replimune Inc.

Cogent Biosciences Announces Positive Lead-In Data from Ongoing Phase 3 PEAK Trial Evaluating Bezuclastinib in Combination with Sunitinib in Patients with Gastrointestinal Stromal Tumors (GIST)

Read more ››

By: GlobeNewswire - 03 Jun 2023

Related companies: Cogent Biosciences, Inc.

Sutro Biopharma Announces Oral Presentation at ASCO 2023 Featuring Data for Luveltamab Tazevibulin from the Phase 1 Dose-Expansion Study in Ovarian Cancer and the Initiation of the Phase 2/3 Pivotal Study REFRaME-O1

Read more ››

By: GlobeNewswire - 03 Jun 2023

Related companies: Sutro Biopharma, Inc.

Gracell Biotechnologies Presents Updated Data of Deep and Durable Responses for FasTCAR-T GC012F in Relapsed/Refractory Multiple Myeloma at 2023 ASCO Annual Meeting

Read more ››

By: PR Newswire Association LLC. - 03 Jun 2023

Janssen Presents First-Ever Results from Dual Bispecific Combination Study Showing 96 Percent Overall Response Rate in Patients with Relapsed or Refractory Multiple Myeloma

Read more ››

By: PR Newswire Association LLC. - 03 Jun 2023

Janssen Presents Longer-Term Talquetamab Follow-Up Data Showing Overall Response Rates of More Than 70 Percent in Heavily Pretreated Patients with Multiple Myeloma

Read more ››

By: PR Newswire Association LLC. - 03 Jun 2023

Zevra Therapeutics Presents Design of Phase 2 Clinical Trial Investigating KP1077 for the Treatment of Idiopathic Hypersomnia (IH) at Beyond Sleepy 2023

Read more ››

By: GlobeNewswire - 03 Jun 2023

Related companies: Zevra Therapeutics, Inc.

Apexigen Announces Phase 2 Data Evaluating Sotigalimab, its CD40 Agonist Antibody, in Combination with Doxorubicin in Patients with Advanced Soft Tissue Sarcoma Presented at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting

Read more ››

By: GlobeNewswire - 03 Jun 2023

Related companies: Apexigen, Inc.

Elicio Therapeutics Announces Positive Interim Data from the Phase 1 Study of an Investigational Therapeutic Cancer Immunotherapy, ELI-002, in Patients with High Relapse Risk Pancreatic and Colorectal Cancer at the ASCO Annual Meeting

Read more ››

By: GlobeNewswire - 03 Jun 2023

Related companies: Elicio Therapeutics

Allogene Therapeutics Presents Updated ALLO-501/501A Phase 1 Data in Large B Cell Lymphoma at the American Society of Clinical Oncology (ASCO) Annual Meeting

Read more ››

By: GlobeNewswire - 03 Jun 2023

Related companies: Allogene Therapeutics, Inc.

Intensity Therapeutics' INT230-6 Prolongs Survival Alone or in Combination With Ipilimumab in Adult Patients with Relapsed, Refractory, Metastatic Sarcomas

Read more ››

By: PR Newswire Association LLC. - 03 Jun 2023

Related companies: Intensity Therapeutics, Inc.

Elevation Oncology Highlights First-in-Human Phase 1 SYSA1801 (EO-3021) Clinical Data to be Presented by Partner CSPC Pharmaceutical Group Limited at ASCO 2023

Read more ››

By: PR Newswire Association LLC. - 03 Jun 2023

Related companies: Elevation Oncology

Blueprint Medicines Highlights Clinical Progress Across Precision Oncology Pipeline at 2023 ASCO Annual Meeting

Read more ››

By: PR Newswire Association LLC. - 03 Jun 2023

Related companies: Blueprint Medicines Corporation

Precigen Announces Positive Phase 1 Data for Off-the-Shelf PRGN-2009 AdenoVerse™ Immunotherapy Alone and in Combination with an Investigational Checkpoint Inhibitor in Patients with Recurrent/Metastatic HPV-associated Cancers

Read more ››

By: PR Newswire Association LLC. - 03 Jun 2023

Related companies: Precigen, Inc.

Sanctuary Cannabis Opens 19th Medical Cannabis Dispensary in Boynton Beach, Florida

Read more ››

By: PR Newswire Association LLC. - 03 Jun 2023

MEDSIR's PHERGain Trial Shows Potential for Chemotherapy-free Treatment of HER2-positive Early Breast Cancer

Read more ››

By: PR Newswire Association LLC. - 03 Jun 2023

Innovent Announces the Second Breakthrough Therapy Designation by NMPA for Olverembatinib for the Treatment of Patients with SDH-Deficient GIST

Read more ››

By: PR Newswire Association LLC. - 03 Jun 2023

Related companies: Innovent Biologics (USA), Inc.

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Read more ››

By: GlobeNewswire - 02 Jun 2023

Related companies: Cytokinetics, Inc.

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 »

Looking for companies outside of the United States?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

June 2023
- Boston: Product & Company Valuation Course
- BIO International Convention 2023
- RESI Boston

Add an Event »

Latest company news

Roswell Park Study May Provide Clues to Treating Colorectal Cancer More Effectively in Younger Patients
04 Jun 2023 (PR Newswire Association LLC.)

Innovent Updates Phase 1b Data of IBI939 (Anti-TIGIT Monoclonal Antibody) Combined with Sintilimab in Previously Untreated PD-L1-selected NSCLC at the 2023 ASCO Annual Meeting
04 Jun 2023 (PR Newswire Association LLC.)

Replimune Presents RP1 Data from the IGNYTE anti-PD1 Failed Melanoma Cohort and RP2 Data in Uveal Melanoma at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
03 Jun 2023 (GlobeNewswire)

Biotechgate database

About Biotechgate
The USA Life Sciences Database is a product of Venture Valuation and part of the global Life Sciences lead generation and intelligence platform Biotechgate. Our mission is to provide up-to-date company and business information of the Biotech, Pharma and Medtech sectors to professionals everywhere, in order to support them in identifying the most appropriate business partners, customers and suppliers.

Visit our global portal: www.biotechgate.com